ATOSSA THERAPEUTICS, INC. Prepaid Expense and Other Assets, Current
ATOSSA THERAPEUTICS, INC. (ATOS) had Prepaid Expense and Other Assets, Current of $1.79 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-07
- 2026-06-30: Prepaid Expense and Other Assets, Current $1.79M.
- 2026-03-31: Prepaid Expense and Other Assets, Current $1.83M.
- 2025-12-31: Prepaid Expense and Other Assets, Current $1.13M.
- 2025-09-30: Prepaid Expense and Other Assets, Current $580.00K.
| Period end | Prepaid Expense and Other Assets, Current |
|---|---|
| 2026-06-30 | $1.79M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $1.83M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $1.13M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $580.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $1.07M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $1.44M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $1.17M 10-K · filed 2026-03-25 |
| 2024-09-30 | $950.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $987.00K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $1.61M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $2.16M 10-K · filed 2025-03-25 |
| 2022-12-31 | $1.21M 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |